A Peptide Approach to Regenerative Medicine - BRIM Biotechnology, Inc.

A Peptide Approach to Regenerative Medicine

Are regenerative peptides the answer to current challenges in the development of treatments for unmet needs?

In an article published in PharmaTimes Magazine, Frank Lee, CSO, and Maria Chen, VP of Business Development, discuss the potential of pigment epithelium-derived factor (PEDF), and explain how PEDF-derived short peptide (PDSP) platforms can promote stem cell generation.

Read the article here.

This article is taken from PharmaTimes Magazine January/February 2022, pages 26-27.

Download BRIM's Corporate Overview